MiniMed Files for IPO, Bets On New Pumps And CGMs Amid Simplera Delays

MiniMed’s Move Toward Independence Puts Pressure On Its Ability To Deliver New Devices While Fixing Simplera Production.

 
• By Shubham Singh
  
MiniMed said it plans to use a portion of the IPO proceeds to repay intercompany debt owed to Medtronic, with the remainder allocated to general corporate purposes. Picture Courtesy: Medtronic

More from Diabetic Care

More from Device Area